Trial ID
21304
Sponsor ID
Toray Industries
A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)
Principal Investigator
Christina Brzezniak, DO
5 Locations
Locations
Alexandria Office
Arlington Office
Fairfax Office
Gainesville Office
Loudoun Office
Learn More About This Trial
Other Relevant Trials
Trial ID
TOS-358-001
Sponsor ID
Totus
A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
NP-G2-044-P2-01
Sponsor ID
Novita
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
